SelectImmune Pharma is a pharmaceutical company. The company intends to develop drug candidates with focus on endogenous inflammatory agents and bacterial molecules. The products are aimed at strengthening the immune system and are mainly used for the treatment of infectious diseases, as well as chronic inflammation. The company was founded in 2017 and has the largest operations in the Nordic market.

Quotes for SelectImmune Pharma AB (publ)

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Gabriela Godaly (tf)

Chairperson of the Board

  • Catharina Svanborg

Board

  • Carl-Johan Wachtmeister
  • Gabriela Godaly
  • Helena Lomberg

Largest Owners

Name Capital % Votes % Date
Catharina Svanborg 45,84 73,33 2023-06-28
Rolf Karlsson 6,42 3,16 2023-06-28
Avanza Pension 3,55 1,75 2023-06-28
Fredrik Herslow 3,47 1,71 2023-06-28
Jan Zetterberg 3,24 1,60 2023-06-28
Swedbank Försäkring 1,72 0,84 2023-06-28
Helena Lomberg 1,46 0,72 2023-06-28
Nordnet Pensionsförsäkring 1,42 0,70 2023-06-28
Monica Strömberg 1,11 0,55 2023-06-28
Peter Ryman 1,02 0,50 2023-06-28

Insider trading

NameTransaction DateTypeInstrumentAmountPriceValueCurrency
Catharina Svanborg2021-06-29Buy TransactionSelectImmune Pharma 16 00013,2211 200,0SEK
Catharina Svanborg2020-12-09Buy TransactionSelectImmune Pharma 3 00013,5140 530,0SEK
Johannes Wullt2020-03-17Buy TransactionSelectImmune Pharma TO 1 B 8002,52 000,0SEK
Johannes Wullt2020-03-17Buy TransactionSelectImmune Pharma TO 1 B 1 0003,693 690,0SEK
Johannes Wullt2020-03-17Buy TransactionSelectImmune Pharma TO 1 B 4 2003,715 540,0SEK
Catharina Svanborg2020-02-21Buy TransactionSelectImmune Pharma 50 00013,55677 500,0SEK
Catharina Svanborg2019-11-08Buy TransactionSelectImmune Pharma 200 00015,53 100 000,0SEK
Johannes Wullt2019-09-26Buy TransactionSelectImmune Pharma 1 33715,7721 084,5SEK
Johannes Wullt2019-09-26Buy TransactionSelectImmune Pharma 1 56315,724 539,1SEK
Johannes Wullt2019-09-26Buy TransactionSelectImmune Pharma 2 53015,7339 796,9SEK
Catharina Svanborg2019-07-10en-USSelectImmune Pharma 50 00000,0SEK
Catharina Svanborg2019-07-04en-USSelectimmune Warrant on series 2019/2020 5 20000,0SEK
Catharina Svanborg2019-07-04en-USSelectImmune Pharma 10 4007,578 000,0SEK
Fredrik Herslow2019-06-19en-USSelectImmune Pharma 40 0007,5300 000,0SEK
Catharina Svanborg2019-06-20Buy TransactionSelectImmune Pharma 12 8007,596 000,0SEK
Linnane Pharma AB2019-06-20en-US 6 40000,0SEK
Erik Sturegård2019-06-20en-US 4 00000,0SEK
Erik Sturegård2019-06-20en-USSelectImmune Pharma 8 0007,560 000,0SEK
Björn Wullt2019-06-14Buy TransactionSelectImmune TO 1B 66 66700,0SEK
Björn Wullt2019-06-14Buy TransactionSelectImmune Pharma 133 3347,51 000 005,0SEK
Catharina Svanborg2019-06-14en-USSelectImmune Pharma- 3 599 9867,5−26 999 895,0SEK
Catharina Svanborg2019-06-14en-USSelectImmune Pharma- 2 000 0007,5−15 000 000,0SEK
*Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

Key Numbers

*Compiled data from Millistream